Sales & Marketing A philosophical look at market turn in the Age of AI, with J... John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.
Patients Providing patient access to new therapies, with Dean Erhardt Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.
Sales & Marketing Sponsored Pushing through barriers to commercial launch success, with ... In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.
Patients Every drug is a story, with Thomas Goetz Thomas Goetz, creator and host of the Drug Story podcast on recognising pharmaceutical medicine as the socially and morally complex market that it is.
R&D Looking to gene therapy for ocular diseases, with Lance Bald... Lance Baldo, CEO of Beacon Therapeutics, discusses the transformative power of gene therapy to deliver meaningful outcomes for severe ocular diseases.
Digital Creating what nature has not from AI and computational molec... Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.